ArticleHealth and quality of life outcomes2017
The Center for Epidemiologic Studies Depression Scale is an adequate screening instrument for depression and anxiety disorder in adults with congential heart disease.
Article in Health and quality of life outcomes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 72 citations in OpenAlex.
- Psychological interventions for depression in adolescent and adult congenital heart disease.The Cochrane database of systematic reviews · 2023Pooled it
- Association of Depression with Subclinical Coronary Atherosclerosis: a Systematic Review.Journal of cardiovascular translational research · 2021Pooled it
- Depression in adults with sickle cell disease: a systematic review of the methodological issues in assessing prevalence of depression.BMC psychology · 2021Pooled it
- Relationships among peri-traumatic circulating endocannabinoids and long-term, negative outcomes following traumatic injury.Psychopharmacology · 2026Article
- Prioritizing Neurocognitive and Psychosocial Outcomes in Adults With Congenital Heart Disease: A Consensus Statement From the Adults With Congenital Heart Disease/Neuro 2024 Conference.Journal of the American Heart Association · 2026Article
- Development and Initial Validation of a Brief, Online Version of the Center for Epidemiological Studies Depression Scale (CES-D): Psychometric Study.JMIR formative research · 2026Article
- Estimating the causal impact of chewing disability on depressive symptoms mediated by loneliness: a longitudinal marginal structural model study of older adults in Singapore.Innovation in aging · 2025Article
- Prevalence, risk factors, and metabolic implications of alcohol use disorders among male workers in Hebei Province, China: a cross-sectional study.Substance abuse treatment, prevention, and policy · 2025Article
- Greater Symptom Burden and Poorer Quality of Life Outcomes Are Associated With The Co-Occurrence of Anxiety and Depression During Cancer Chemotherapy.Seminars in oncology nursing · 2025Article
- Psychometric properties of the Chinese-version Behavioral Inhibition System/Behavioral Activation System Scales among stroke survivors with depressive symptoms.International journal of nursing sciences · 2025Article
- The Risk of Depressive Symptoms according to the Dietary Intake of Vitamin C.Neuropsychobiology · 2025Article
- Racial Differences in Older Adult's Mental Health and Cognitive Symptomatology: Identifying Subgroups Using Multiple-Group Latent Class Analysis.Journal of aging and health · 2024Article
- Depression in Cardiac Patients Is a Major Cardiovascular Event Risk Factor: A 12-Month Observational Study.Journal of clinical medicine · 2024Article
- Association between maternal perinatal stress and depression and infant DNA methylation in the first year of life.Translational psychiatry · 2024Article
- Trajectories of depressive symptoms early in the course of bereavement: Patterns, psychosocial factors and risk of prolonged grief.Stress and health : journal of the International Society for the Investigation of Stress · 2024Article
- Demographic, health, physical activity, and workplace factors are associated with lower healthy working life expectancy and life expectancy at age 50.Scientific reports · 2024Article
- Group Interpersonal Psychotherapy for minoritized Head Start mothers with depressive symptoms: A mixed method study.Journal of counseling and development : JCD · 2024Article
- Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients.Journal of psychosocial oncology · 2024Article
- Article
- Mental health in adult congenital heart disease.International journal of cardiology. Congenital heart disease · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Center for Epidemiological Studies Depression Scale (CES-D) is an instrument that is commonly used to screen for depression in patients with chronic disease, but the characteristics of the CES-D in adults with congenital heart disease (CHD) have not yet been studied. The aim of this study was to investigate the criterion validities and the predictive powers of the CES-D for depression and anxiety disorders in adults with CHD.
methodsTwo hundred patients were screened with the CES-D and secondarily interviewed with a diagnostic instrument, i.e., the Mini International Neuropsychiatric Instrument. The sensitivity and specificity values of the CES-D were calculated by cross-tabulation at different cutoff scores. Receiver operating characteristic (ROC) curves were used to assess the optimal cutoff point for each disorder and to assess the predictive power of the instrument.
resultsThe CES-D exhibited satisfactory criterion validities for depression and for all combinations of depression and/or anxiety. With a desired sensitivity of at least 80%, the optimal cutoff scores were 18. The predictive power of the CES-D in the patients was best for major depression and dysthymia (area under the ROC curve: 0.92) followed by the score for any combination of depression and/or anxiety (0.88).
conclusionThe use of CES-D to simultaneously screen for both depression and anxiety disorders may be useful in adults with CHD.
trial registrationCESDEP 212. Registered 2 March 2014 (retrospectively registered).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.